Journal of Medicinal Chemistry · 2008 · 52 citations · 39 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoverySteroid BiochemistryEnzyme InhibitionLigand-based DesignPharmacophore ScreeningPharmacophore-based Lead DiscoveryStructure-based Pharmacophore ModelingVirtual ScreeningAromatase ActivityAromatase InhibitionAromatase InhibitorsHigh-throughput Virtual ScreeningInhibitor ScreeningLigand-based Pharmacophore ScreeningLigand-based ScreeningSteroid Hormone Biosynthesis Inhibition
Suppression of estrogen biosynthesis by aromatase inhibition is an effective approach for the treatment of hormone sensitive breast cancer. Third generation non-steroid aromatase inhibitors have shown important benefits in recent clinical trials with postmenopausal women. In this study we have developed a new ligand-based strategy combining important pharmacophoric and structural features according to the postulated aromatase binding mode, useful for the virtual screening of new potent non-steroid inhibitors. A small subset of promising drug candidates was identified from the large NCI database, and their antiaromatase activity was assessed on an in vitro biochemical assay with aromatase extracted from human term placenta. New potent aromatase inhibitors were discovered to be active in the low nanomolar range, and a common binding mode was proposed. These results confirm the potential of our methodology for a fast in silico high-throughput screening of potent non-steroid aromatase inhibitors.
39
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Pamela A. Williams, José Cosme, Alison Ward et al. · Nature · 2003 · 817 citations
Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone
Pamela A. Williams, José Cosme, Dijana Matak‐Vinković et al. · Science · 2004 · 806 citations
Medicine, Biochemistry, Pharmacology +15
Biological Aromatization of Steroids
Kenneth J. Ryan · Journal of Biological Chemistry · 1959 · 595 citations · Full text